GNTbm-TKI

N/A

Report date: 2025/11/21 10:34:06

Base Information

Drug NameGNTbm-TKI
Drug Alias NameGNTbm-TKIGNTbmTKI
ClassificationOther
Mechanisms of ActionTYRO3 protein tyrosine kinase inhibitorsAXL receptor tyrosine kinase inhibitorsTyrosine-protein kinase Mer inhibitors +[8] 
TargetsTYRO3 protein tyrosine kinaseAXL receptor tyrosine kinaseTyrosine-protein kinase Mer +[7] 
Therapy Area/IndicationsSolid tumoursNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGreat Novel Therapeutics Biotech & Medicals Corp
China Registration ClassN/A

Develop Information

Active CompaniesGreat Novel Therapeutics Biotech & Medicals Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A